Orbimed Advisors Llc bought $20.0M of Electra Therapeutics (ETRA)

Executed Sep 21, disclosed Sep 23, 2 days later.

Value, as filed

$20.0M

1,333,333 sh across 2 lots

Executed

Sep 21

the trade date, as filed

Disclosed

Sep 23

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

not yet measured

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

The filer

OL Orbimed Advisors Llc Director profile →

Orbimed Advisors Llc (Director) filed 16 Form 4 reports as a reporting entity in the trailing twelve months (8 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Sionna Therapeutics, Inc. (SION). Across 7 priced purchase filings, the average 21-session return was +16.9% from execution and +18.9% from disclosure (delay-adjusted; derived). The largest single filing was $38.9M of ELVN (858,646 sh across 3 lots, as filed), executed Jun 22.

The name

ETRA

Electra Therapeutics, Inc. ETRA · Healthcare · 2 filings in 24 months ticker →

Healthcare · Electra Therapeutics, Inc. is a clinical-stage biotechnology company

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→